YOLFTbeta
MedMira Inc

MedMira Inc

MIR · V · Healthcare / Biotechnology

0.035CAD-0.01 (-22.22%)

Price History

Full chart

Market Stats

Previous Close0.045
Open0.045
Day Range0.03 – 0.045
52-Week Range0.05 – 0.11
Volume395.29K
Market Cap42.10M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.80
50-Day Avg0.0672
200-Day Avg0.067

About

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Hermes Chan
  • Employees0
  • Headquarters155 Chain Lake Drive, Halifax, NS, Canada, B3S 1B3, Canada
  • Websitehttps://medmira.com

Leadership

  • Mr. Hermes ChanCo-Founder, CEO, President & Director
  • Mr. Markus M. MeileChief Financial Officer
  • Dr. Sam RatnamDirector of Scientific & Regulatory Affairs
  • Stewart McKelveyLegal Counsel

Financials

Income Statement

Currency: CAD2000-07-312001-07-312002-07-312003-07-312004-07-312005-07-312006-07-312007-07-312008-07-312009-07-312010-07-312011-07-312012-07-312013-07-312014-07-312015-07-312016-07-312017-07-312018-07-312019-07-312020-07-312021-07-312022-07-312023-07-312024-07-312025-07-31
Total Revenue78.43K373.68K114.64K1.18M2.44M2.66M2.09M1.71M1.52M1.14M1.07M909.87K970.63K2.00M2.53M4.05M2.26M747.34K588.87K527.45K919.07K2.14M952.13K432.53K412.57K240.51K
Growth (%)-+376.46%-69.32%+926.21%+107.30%+9.10%-21.40%-18.46%-10.60%-25.38%-5.67%-15.22%+6.68%+106.20%+26.32%+60.29%-44.31%-66.89%-21.20%-10.43%+74.25%+133.33%-55.60%-54.57%-4.61%-41.70%
Cost of Revenue28.33K342.24K448.08K749.84K1.15M1.57M950.08K906.33K986.30K580.24K338.15K493.91K376.39K1.37M1.75M2.87M1.24M269.05K127.76K104.09K346.79K422.73K648.10K132.15K186.08K67.66K
Gross Profit50.10K31.44K-333.44K426.66K1.29M1.09M1.14M798.99K538.22K557.41K735.02K415.95K594.24K630.77K774.79K1.18M1.02M478.30K461.11K423.35K572.28K1.72M304.03K300.38K226.49K172.85K
Gross Margin63.88%8.41%-290.84%36.27%52.70%40.83%54.57%46.85%35.30%49.00%68.49%45.72%61.22%31.52%30.65%29.13%45.16%64.00%78.30%80.26%62.27%80.29%31.93%69.45%54.90%71.87%
Operating Expense3.36M6.73M4.78M4.74M4.78M5.53M6.62M4.37M3.79M3.08M3.07M2.27M2.75M2.80M4.34M3.65M5.50M2.61M2.30M1.72M1.87M1.91M1.76M2.24M2.66M3.62M
Operating Income-3.31M-6.70M-5.11M-4.31M-3.49M-4.45M-5.48M-3.57M-3.25M-2.53M-2.34M-1.86M-2.16M-2.17M-3.57M-2.47M-4.48M-2.13M-1.84M-1.30M-1.30M-184.23K-1.45M-1.94M-2.43M-3.45M
Operating Margin-4216.38%-1793.05%-4459.52%-366.40%-143.28%-167.15%-261.95%-209.37%-213.09%-222.10%-217.79%-204.11%-222.58%-108.19%-141.15%-60.99%-198.46%-285.43%-312.51%-245.72%-141.46%-8.59%-152.63%-449.52%-588.97%-1433.98%
EBITDA-2.99M-6.33M-4.79M-3.96M-3.16M-4.33M-5.27M-3.35M-3.23M-2.48M-2.30M-1.30M-2.14M-2.41M-3.09M-2.38M-4.12M-2.11M-1.75M-1.28M-1.13M185.30K-1.07M-1.58M-2.13M-3.13M
EBITDA Margin-3806.44%-1694.50%-4176.94%-337.02%-129.59%-162.92%-251.94%-196.61%-211.55%-218.40%-214.67%-142.38%-220.59%-120.45%-122.18%-58.67%-182.52%-282.65%-296.42%-242.14%-122.58%8.64%-112.09%-364.66%-517.33%-1301.53%
Net Income-2.90M-7.20M-5.66M-4.62M-3.99M-6.11M-7.29M-6.29M-7.02M-5.26M-4.42M-4.89M3.37M-402.30K-3.84M-3.23M-5.16M-2.66M-2.51M-2.11M-2.05M-675.80K-1.83M-2.68M-3.33M-4.52M
Net Income Margin-3694.04%-1925.81%-4935.31%-392.35%-163.71%-229.51%-348.46%-368.70%-460.34%-462.64%-411.74%-537.68%347.43%-20.10%-151.70%-79.70%-228.57%-356.07%-426.15%-399.37%-222.55%-31.51%-192.37%-618.61%-806.25%-1881.18%
R&D761.22K1.70M1.20M819.35K502.58K471.73K653.62K329.25K333.60K317.30K332.36K275.27K199.02K133.30K294.43K604.14K2.52M292.30K522.94K317.35K199.27K359.32K191.14K470.68K476.89K1.31M
R&D as % of Total Revenue970.59%454.17%1044.40%69.64%20.61%17.73%31.25%19.31%21.88%27.89%30.97%30.25%20.50%6.66%11.65%14.91%111.60%39.11%88.80%60.17%21.68%16.76%20.07%108.82%115.59%545.16%
Interest Expense---------2.47M2.40M3.60M3.79M734.60K760.71K769.19K939.56K449.89K697.17K810.41K725.63K653.30K552.03K885.52K882.41K1.08M
Interest Expense % of Total Revenue---------216.76%223.19%396.06%390.46%36.70%30.09%18.98%41.63%60.20%118.39%153.65%78.95%30.46%57.98%204.73%213.88%447.61%

Balance Sheet

Currency: CAD2000-07-312001-07-312002-07-312003-07-312004-07-312005-07-312006-07-312007-07-312008-07-312009-07-312010-07-312011-07-312012-07-312013-07-312014-07-312015-07-312016-07-312017-07-312018-07-312019-07-312020-07-312021-07-312022-07-312023-07-312024-07-312025-07-31
Total Assets3.62M3.03M3.36M2.36M1.69M1.43M4.01M2.86M833.19K523.41K568.18K1.49M2.97M1.17M1.84M1.78M869.90K673.71K300.91K252.52K3.40M3.89M3.83M3.65M6.07M3.68M
Total Liabilities6.89M9.03M10.81M4.55M7.57M11.23M12.05M15.64M14.77M16.52M17.23M20.61M11.68M10.28M8.53M9.49M8.53M9.66M11.70M13.77M18.96M19.61M16.19M18.68M24.11M26.24M
Total Equity-3.28M-6.01M-7.45M-2.19M-5.87M-9.80M-8.05M-12.78M-13.94M-16.00M-16.66M-19.11M-8.71M-9.11M-6.69M-7.70M-7.66M-8.98M-11.40M-13.52M-15.56M-15.72M-12.36M-15.03M-18.04M-22.56M
Cash-5.94M51.84K1.04M264.29K-28.76K-----1.03M2.42M20.94K162.46K262.39K46.12K155.91K088.90K401.86K-2.30M33.46K13.18K2.10M14.91K
Total Debt6.03M37.49K9.49M1.92M4.63M8.17M9.43M10.23M10.71M11.72M12.75M14.65M7.41M6.87M6.22M6.96M6.25M6.94M7.58M8.61M11.91M11.54M8.30M9.27M--
Net Debt11.98M-14.35K8.45M1.66M4.63M8.14M9.43M10.23M10.71M11.72M12.75M13.63M5.00M6.85M6.06M6.69M6.20M6.78M7.58M8.52M11.51M13.84M8.27M9.26M4.90M8.30M

Cash Flow

Currency: CAD2000-07-312001-07-312002-07-312003-07-312004-07-312005-07-312006-07-312007-07-312008-07-312009-07-312010-07-312011-07-312012-07-312013-07-312014-07-312015-07-312016-07-312017-07-312018-07-312019-07-312020-07-312021-07-312022-07-312023-07-312024-07-312025-07-31
Operating Cash Flow-3.05M-6.08M-3.66M-2.99M-3.08M-5.37M-7.54M-2.10M-3.23M-2.02M-2.64M-1.69M---4.66M-2.35M-4.09M-1.89M-795.41K-941.13K-315.90K-504.64K-1.88M-1.27M-2.94M-3.15M
Investing Cash Flow---------------96.29K-27.25K-27.25K307-3.34K3.34K-101.88K-36.55K-69.72K---
Financing Cash Flow2.95M-105.40K4.64M2.25M3.02M5.43M7.78M2.10M3.10M2.00M2.69M2.73M3.56M58.49K4.82M2.45M3.90M2.00M642.83K1.03M730.74K139.32K1.99M1.25M5.77M1.07M
Capital Expenditure401.83K306.24K12.30K109.35K200.13K6.64K99.01K1.51K0055.50K6.82K5.71K366.99K96.29K27.25K27.25K3.34K3.34K101.88K101.88K36.55K69.72K1.27K742.53K7.47K
Free Cash Flow-3.45M-6.38M-3.67M-3.10M-3.28M-5.38M-7.64M-2.10M-3.23M-2.02M-2.69M-1.70M-5.71K-366.99K-96.29K-2.35M-4.12M-1.89M-798.75K-941.13K-417.78K-541.19K-1.95M-1.27M-3.68M-3.15M
Dividends Paid------------523.22K-------------
FCF to OCF113.17%105.04%100.34%103.66%106.50%100.12%101.31%100.07%100.00%100.00%102.10%100.40%--2.07%100.00%100.67%100.00%100.42%100.00%132.25%107.24%103.70%100.10%125.27%100.24%
Dividend Paid to FCF-------------9166.43%-------------

Earnings

Report DateSep 15, 2003Nov 24, 2003Mar 22, 2004Jun 29, 2004Sep 24, 2004Dec 13, 2004Mar 21, 2005Jun 29, 2005Sep 30, 2005Dec 19, 2005Feb 16, 2006Jun 29, 2006Sep 30, 2006Nov 29, 2006Mar 2, 2007Jun 28, 2007Dec 28, 2007Mar 18, 2008Jun 26, 2008Sep 29, 2008Nov 26, 2008Feb 27, 2009Jun 26, 2009Sep 28, 2009Dec 30, 2009Mar 26, 2010Jun 29, 2010Dec 29, 2010Apr 1, 2011Jun 29, 2011Sep 28, 2011Jan 27, 2012Mar 30, 2012Jun 29, 2012Dec 28, 2012Mar 1, 2013Jun 28, 2013Dec 9, 2013Feb 28, 2014Jul 1, 2014Oct 1, 2014Dec 26, 2014Mar 27, 2015May 29, 2015Dec 25, 2015Apr 1, 2016Jun 24, 2016Dec 30, 2016Mar 31, 2017Jun 29, 2017Sep 27, 2017Dec 22, 2017Mar 29, 2018Jun 29, 2018Dec 19, 2018Mar 29, 2019Jun 28, 2019Dec 18, 2019Mar 31, 2020May 29, 2020Dec 24, 2020Mar 31, 2021Jun 25, 2021Dec 30, 2021Mar 31, 2022Jun 30, 2022Dec 30, 2022Apr 4, 2023Jun 29, 2023Nov 27, 2026
EPS Estimate-0.01--0.03-0.03-0.02-----------------------------------------------------------------
EPS Actual-0.02-0.02-0.02-0.03-0.02-0.03-0.03-0.03-0.05-0.04-0.03-0.05-0.04-0.03-0.03-0.02-0.02-0.01-0.02-0.04-0.02-0.01-0.01-0.01-0.01-0.01-0.00-0.01-0.01-0.00-0.01-0.01-0.01-0.010.000.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-
Surprise-100.00%-33.33%0.00%0.00%-----------------------------------------------------------------
Timing-----------------------------------------------After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours---------After-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap42.10M
Enterprise Value55.44M
Trailing P/E0.00
Forward P/E0.00
Price / Sales113.62
Price / Book0.00
EPS0.00
Book Value-0.035
Revenue (TTM)370.57K
Gross Profit (TTM)-485.18K
EBITDA-1.94M
Profit Margin0.00%
Operating Margin-109.79%
Return on Equity0.00%
Return on Assets-34.28%
Shares Outstanding701.73M
Shares Float209.72M
Beta0.80
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%